Toronto Stocks Inch Lower, Nuvei Shares Jump on 3Q Earnings, Narrowed Outlook
By Adriano Marchese
Canadian stocks were slightly lower Wednesday.
Sector performance was mixed. Gains were primarily in consumer discretionary, tech services and producer manufacturing, offset by losses in energy, materials and communications.
At midday, Canada's S&P/TSX Composite Index was 0.13% lower at 19546.67. The blue-chip S&P/TSX 60 fell by 0.10% to 1176.90.
Nuvei's shares climbed by over 18% to 25.70 Canadian dollars ($18.67) after the Canadian financial technology company met its guidance for the recent quarter and narrowed its revenue target for the full year.
Other market movers:
ATS shares were higher 9.7% higher at C$51.10 after the Canadian automation systems company reported higher profit and a revenue beat in its second quarter of the fiscal year.
Thinkific Labs shares were 15% higher at C$2.60 after the company reported a narrowed loss and revenue growth in its third quarter and said it will launch a share-repurchase program.
Goeasy's earnings and revenue topped expectations for the recent quarter after the consumer lender saw a record volume of applications for credit. Shares were 5.6% higher at C$126.77.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
November 08, 2023 12:32 ET (17:32 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks